Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients

This publication has 62 references indexed in Scilit:

• The association between diet quality, dietary patterns and depression in adults: a systematic review
  BMC Psychiatry, 2013
• Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
  The Lancet, 2013
• DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a Cross-Sectional Analysis
  BMC Cancer, 2012
• Body mass index and survival after breast cancer diagnosis in Japanese women
  BMC Cancer, 2012
• Aromatase, breast cancer and obesity: a complex interaction
  Trends in Endocrinology & Metabolism, 2012
• The Warburg effect in 2012
  Current Opinion in Oncology, 2012
• Clinical and biomarker predictors of side effects from tamoxifen
  Breast Cancer Research and Treatment, 2011
• Weight Change and Its Correlates Among Breast Cancer Survivors
  Nutrition and Cancer, 2011
• Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
  Annals of Oncology, 2011
• Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective study
  Clinical Nutrition, 2010